The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Prostate Cancer Diagnostics and Therapy Market Research Report 2025
Synopsis
The global Prostate Cancer Diagnostics and Therapy market was valued at US$ 13430 million in 2023 and is anticipated to reach US$ 17600 million by 2030, witnessing a CAGR of 4.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Diagnostics and Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Diagnostics and Therapy.
Report Scope
The Prostate Cancer Diagnostics and Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prostate Cancer Diagnostics and Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prostate Cancer Diagnostics and Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Ipsen SA
Pfizer Inc.
Johnson & Johnson Services Inc.
Bayer AG
Abbvie Inc.
Merck & Co. Inc.
AstraZeneca PLC
Thermo Fisher Scientific
Dendreon Pharmaceuticals LLC
F. Hoffmann-La Roche Ltd
Hologic Inc.
Astellas Pharma Inc.
Koninklijke Philips NV
Sanofi-Aventis
Segment by Type
Androgen Receptor-Directed Therapy
Taxane-Based Chemotherapy
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prostate Cancer Diagnostics and Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Prostate Cancer Diagnostics and Therapy market was valued at US$ 13430 million in 2023 and is anticipated to reach US$ 17600 million by 2030, witnessing a CAGR of 4.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Diagnostics and Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Diagnostics and Therapy.
Report Scope
The Prostate Cancer Diagnostics and Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prostate Cancer Diagnostics and Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prostate Cancer Diagnostics and Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Ipsen SA
Pfizer Inc.
Johnson & Johnson Services Inc.
Bayer AG
Abbvie Inc.
Merck & Co. Inc.
AstraZeneca PLC
Thermo Fisher Scientific
Dendreon Pharmaceuticals LLC
F. Hoffmann-La Roche Ltd
Hologic Inc.
Astellas Pharma Inc.
Koninklijke Philips NV
Sanofi-Aventis
Segment by Type
Androgen Receptor-Directed Therapy
Taxane-Based Chemotherapy
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prostate Cancer Diagnostics and Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Cancer Diagnostics and Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Androgen Receptor-Directed Therapy
1.2.3 Taxane-Based Chemotherapy
1.3 Market by Application
1.3.1 Global Prostate Cancer Diagnostics and Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prostate Cancer Diagnostics and Therapy Market Perspective (2019-2030)
2.2 Prostate Cancer Diagnostics and Therapy Growth Trends by Region
2.2.1 Global Prostate Cancer Diagnostics and Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Prostate Cancer Diagnostics and Therapy Historic Market Size by Region (2019-2024)
2.2.3 Prostate Cancer Diagnostics and Therapy Forecasted Market Size by Region (2025-2030)
2.3 Prostate Cancer Diagnostics and Therapy Market Dynamics
2.3.1 Prostate Cancer Diagnostics and Therapy Industry Trends
2.3.2 Prostate Cancer Diagnostics and Therapy Market Drivers
2.3.3 Prostate Cancer Diagnostics and Therapy Market Challenges
2.3.4 Prostate Cancer Diagnostics and Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prostate Cancer Diagnostics and Therapy Players by Revenue
3.1.1 Global Top Prostate Cancer Diagnostics and Therapy Players by Revenue (2019-2024)
3.1.2 Global Prostate Cancer Diagnostics and Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Prostate Cancer Diagnostics and Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Prostate Cancer Diagnostics and Therapy Revenue
3.4 Global Prostate Cancer Diagnostics and Therapy Market Concentration Ratio
3.4.1 Global Prostate Cancer Diagnostics and Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Diagnostics and Therapy Revenue in 2023
3.5 Prostate Cancer Diagnostics and Therapy Key Players Head office and Area Served
3.6 Key Players Prostate Cancer Diagnostics and Therapy Product Solution and Service
3.7 Date of Enter into Prostate Cancer Diagnostics and Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate Cancer Diagnostics and Therapy Breakdown Data by Type
4.1 Global Prostate Cancer Diagnostics and Therapy Historic Market Size by Type (2019-2024)
4.2 Global Prostate Cancer Diagnostics and Therapy Forecasted Market Size by Type (2025-2030)
5 Prostate Cancer Diagnostics and Therapy Breakdown Data by Application
5.1 Global Prostate Cancer Diagnostics and Therapy Historic Market Size by Application (2019-2024)
5.2 Global Prostate Cancer Diagnostics and Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Prostate Cancer Diagnostics and Therapy Market Size (2019-2030)
6.2 North America Prostate Cancer Diagnostics and Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Prostate Cancer Diagnostics and Therapy Market Size by Country (2019-2024)
6.4 North America Prostate Cancer Diagnostics and Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Prostate Cancer Diagnostics and Therapy Market Size (2019-2030)
7.2 Europe Prostate Cancer Diagnostics and Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Prostate Cancer Diagnostics and Therapy Market Size by Country (2019-2024)
7.4 Europe Prostate Cancer Diagnostics and Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prostate Cancer Diagnostics and Therapy Market Size (2019-2030)
8.2 Asia-Pacific Prostate Cancer Diagnostics and Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Prostate Cancer Diagnostics and Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Prostate Cancer Diagnostics and Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Prostate Cancer Diagnostics and Therapy Market Size (2019-2030)
9.2 Latin America Prostate Cancer Diagnostics and Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Prostate Cancer Diagnostics and Therapy Market Size by Country (2019-2024)
9.4 Latin America Prostate Cancer Diagnostics and Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Size (2019-2030)
10.2 Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Ipsen SA
11.1.1 Ipsen SA Company Detail
11.1.2 Ipsen SA Business Overview
11.1.3 Ipsen SA Prostate Cancer Diagnostics and Therapy Introduction
11.1.4 Ipsen SA Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024)
11.1.5 Ipsen SA Recent Development
11.2 Pfizer Inc.
11.2.1 Pfizer Inc. Company Detail
11.2.2 Pfizer Inc. Business Overview
11.2.3 Pfizer Inc. Prostate Cancer Diagnostics and Therapy Introduction
11.2.4 Pfizer Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024)
11.2.5 Pfizer Inc. Recent Development
11.3 Johnson & Johnson Services Inc.
11.3.1 Johnson & Johnson Services Inc. Company Detail
11.3.2 Johnson & Johnson Services Inc. Business Overview
11.3.3 Johnson & Johnson Services Inc. Prostate Cancer Diagnostics and Therapy Introduction
11.3.4 Johnson & Johnson Services Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024)
11.3.5 Johnson & Johnson Services Inc. Recent Development
11.4 Bayer AG
11.4.1 Bayer AG Company Detail
11.4.2 Bayer AG Business Overview
11.4.3 Bayer AG Prostate Cancer Diagnostics and Therapy Introduction
11.4.4 Bayer AG Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024)
11.4.5 Bayer AG Recent Development
11.5 Abbvie Inc.
11.5.1 Abbvie Inc. Company Detail
11.5.2 Abbvie Inc. Business Overview
11.5.3 Abbvie Inc. Prostate Cancer Diagnostics and Therapy Introduction
11.5.4 Abbvie Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024)
11.5.5 Abbvie Inc. Recent Development
11.6 Merck & Co. Inc.
11.6.1 Merck & Co. Inc. Company Detail
11.6.2 Merck & Co. Inc. Business Overview
11.6.3 Merck & Co. Inc. Prostate Cancer Diagnostics and Therapy Introduction
11.6.4 Merck & Co. Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024)
11.6.5 Merck & Co. Inc. Recent Development
11.7 AstraZeneca PLC
11.7.1 AstraZeneca PLC Company Detail
11.7.2 AstraZeneca PLC Business Overview
11.7.3 AstraZeneca PLC Prostate Cancer Diagnostics and Therapy Introduction
11.7.4 AstraZeneca PLC Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024)
11.7.5 AstraZeneca PLC Recent Development
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Detail
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific Prostate Cancer Diagnostics and Therapy Introduction
11.8.4 Thermo Fisher Scientific Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024)
11.8.5 Thermo Fisher Scientific Recent Development
11.9 Dendreon Pharmaceuticals LLC
11.9.1 Dendreon Pharmaceuticals LLC Company Detail
11.9.2 Dendreon Pharmaceuticals LLC Business Overview
11.9.3 Dendreon Pharmaceuticals LLC Prostate Cancer Diagnostics and Therapy Introduction
11.9.4 Dendreon Pharmaceuticals LLC Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024)
11.9.5 Dendreon Pharmaceuticals LLC Recent Development
11.10 F. Hoffmann-La Roche Ltd
11.10.1 F. Hoffmann-La Roche Ltd Company Detail
11.10.2 F. Hoffmann-La Roche Ltd Business Overview
11.10.3 F. Hoffmann-La Roche Ltd Prostate Cancer Diagnostics and Therapy Introduction
11.10.4 F. Hoffmann-La Roche Ltd Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024)
11.10.5 F. Hoffmann-La Roche Ltd Recent Development
11.11 Hologic Inc.
11.11.1 Hologic Inc. Company Detail
11.11.2 Hologic Inc. Business Overview
11.11.3 Hologic Inc. Prostate Cancer Diagnostics and Therapy Introduction
11.11.4 Hologic Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024)
11.11.5 Hologic Inc. Recent Development
11.12 Astellas Pharma Inc.
11.12.1 Astellas Pharma Inc. Company Detail
11.12.2 Astellas Pharma Inc. Business Overview
11.12.3 Astellas Pharma Inc. Prostate Cancer Diagnostics and Therapy Introduction
11.12.4 Astellas Pharma Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024)
11.12.5 Astellas Pharma Inc. Recent Development
11.13 Koninklijke Philips NV
11.13.1 Koninklijke Philips NV Company Detail
11.13.2 Koninklijke Philips NV Business Overview
11.13.3 Koninklijke Philips NV Prostate Cancer Diagnostics and Therapy Introduction
11.13.4 Koninklijke Philips NV Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024)
11.13.5 Koninklijke Philips NV Recent Development
11.14 Sanofi-Aventis
11.14.1 Sanofi-Aventis Company Detail
11.14.2 Sanofi-Aventis Business Overview
11.14.3 Sanofi-Aventis Prostate Cancer Diagnostics and Therapy Introduction
11.14.4 Sanofi-Aventis Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024)
11.14.5 Sanofi-Aventis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Prostate Cancer Diagnostics and Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Androgen Receptor-Directed Therapy
Table 3. Key Players of Taxane-Based Chemotherapy
Table 4. Global Prostate Cancer Diagnostics and Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Prostate Cancer Diagnostics and Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Prostate Cancer Diagnostics and Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Prostate Cancer Diagnostics and Therapy Market Share by Region (2019-2024)
Table 8. Global Prostate Cancer Diagnostics and Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Prostate Cancer Diagnostics and Therapy Market Share by Region (2025-2030)
Table 10. Prostate Cancer Diagnostics and Therapy Market Trends
Table 11. Prostate Cancer Diagnostics and Therapy Market Drivers
Table 12. Prostate Cancer Diagnostics and Therapy Market Challenges
Table 13. Prostate Cancer Diagnostics and Therapy Market Restraints
Table 14. Global Prostate Cancer Diagnostics and Therapy Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Prostate Cancer Diagnostics and Therapy Market Share by Players (2019-2024)
Table 16. Global Top Prostate Cancer Diagnostics and Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Diagnostics and Therapy as of 2023)
Table 17. Ranking of Global Top Prostate Cancer Diagnostics and Therapy Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Prostate Cancer Diagnostics and Therapy Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Prostate Cancer Diagnostics and Therapy Product Solution and Service
Table 21. Date of Enter into Prostate Cancer Diagnostics and Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Prostate Cancer Diagnostics and Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Prostate Cancer Diagnostics and Therapy Revenue Market Share by Type (2019-2024)
Table 25. Global Prostate Cancer Diagnostics and Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Prostate Cancer Diagnostics and Therapy Revenue Market Share by Type (2025-2030)
Table 27. Global Prostate Cancer Diagnostics and Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Prostate Cancer Diagnostics and Therapy Revenue Market Share by Application (2019-2024)
Table 29. Global Prostate Cancer Diagnostics and Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Prostate Cancer Diagnostics and Therapy Revenue Market Share by Application (2025-2030)
Table 31. North America Prostate Cancer Diagnostics and Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Prostate Cancer Diagnostics and Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Prostate Cancer Diagnostics and Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Prostate Cancer Diagnostics and Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Prostate Cancer Diagnostics and Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Prostate Cancer Diagnostics and Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Prostate Cancer Diagnostics and Therapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Prostate Cancer Diagnostics and Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Prostate Cancer Diagnostics and Therapy Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Prostate Cancer Diagnostics and Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Prostate Cancer Diagnostics and Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Prostate Cancer Diagnostics and Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 46. Ipsen SA Company Detail
Table 47. Ipsen SA Business Overview
Table 48. Ipsen SA Prostate Cancer Diagnostics and Therapy Product
Table 49. Ipsen SA Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024) & (US$ Million)
Table 50. Ipsen SA Recent Development
Table 51. Pfizer Inc. Company Detail
Table 52. Pfizer Inc. Business Overview
Table 53. Pfizer Inc. Prostate Cancer Diagnostics and Therapy Product
Table 54. Pfizer Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024) & (US$ Million)
Table 55. Pfizer Inc. Recent Development
Table 56. Johnson & Johnson Services Inc. Company Detail
Table 57. Johnson & Johnson Services Inc. Business Overview
Table 58. Johnson & Johnson Services Inc. Prostate Cancer Diagnostics and Therapy Product
Table 59. Johnson & Johnson Services Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024) & (US$ Million)
Table 60. Johnson & Johnson Services Inc. Recent Development
Table 61. Bayer AG Company Detail
Table 62. Bayer AG Business Overview
Table 63. Bayer AG Prostate Cancer Diagnostics and Therapy Product
Table 64. Bayer AG Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024) & (US$ Million)
Table 65. Bayer AG Recent Development
Table 66. Abbvie Inc. Company Detail
Table 67. Abbvie Inc. Business Overview
Table 68. Abbvie Inc. Prostate Cancer Diagnostics and Therapy Product
Table 69. Abbvie Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024) & (US$ Million)
Table 70. Abbvie Inc. Recent Development
Table 71. Merck & Co. Inc. Company Detail
Table 72. Merck & Co. Inc. Business Overview
Table 73. Merck & Co. Inc. Prostate Cancer Diagnostics and Therapy Product
Table 74. Merck & Co. Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024) & (US$ Million)
Table 75. Merck & Co. Inc. Recent Development
Table 76. AstraZeneca PLC Company Detail
Table 77. AstraZeneca PLC Business Overview
Table 78. AstraZeneca PLC Prostate Cancer Diagnostics and Therapy Product
Table 79. AstraZeneca PLC Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024) & (US$ Million)
Table 80. AstraZeneca PLC Recent Development
Table 81. Thermo Fisher Scientific Company Detail
Table 82. Thermo Fisher Scientific Business Overview
Table 83. Thermo Fisher Scientific Prostate Cancer Diagnostics and Therapy Product
Table 84. Thermo Fisher Scientific Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024) & (US$ Million)
Table 85. Thermo Fisher Scientific Recent Development
Table 86. Dendreon Pharmaceuticals LLC Company Detail
Table 87. Dendreon Pharmaceuticals LLC Business Overview
Table 88. Dendreon Pharmaceuticals LLC Prostate Cancer Diagnostics and Therapy Product
Table 89. Dendreon Pharmaceuticals LLC Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024) & (US$ Million)
Table 90. Dendreon Pharmaceuticals LLC Recent Development
Table 91. F. Hoffmann-La Roche Ltd Company Detail
Table 92. F. Hoffmann-La Roche Ltd Business Overview
Table 93. F. Hoffmann-La Roche Ltd Prostate Cancer Diagnostics and Therapy Product
Table 94. F. Hoffmann-La Roche Ltd Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024) & (US$ Million)
Table 95. F. Hoffmann-La Roche Ltd Recent Development
Table 96. Hologic Inc. Company Detail
Table 97. Hologic Inc. Business Overview
Table 98. Hologic Inc. Prostate Cancer Diagnostics and Therapy Product
Table 99. Hologic Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024) & (US$ Million)
Table 100. Hologic Inc. Recent Development
Table 101. Astellas Pharma Inc. Company Detail
Table 102. Astellas Pharma Inc. Business Overview
Table 103. Astellas Pharma Inc. Prostate Cancer Diagnostics and Therapy Product
Table 104. Astellas Pharma Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024) & (US$ Million)
Table 105. Astellas Pharma Inc. Recent Development
Table 106. Koninklijke Philips NV Company Detail
Table 107. Koninklijke Philips NV Business Overview
Table 108. Koninklijke Philips NV Prostate Cancer Diagnostics and Therapy Product
Table 109. Koninklijke Philips NV Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024) & (US$ Million)
Table 110. Koninklijke Philips NV Recent Development
Table 111. Sanofi-Aventis Company Detail
Table 112. Sanofi-Aventis Business Overview
Table 113. Sanofi-Aventis Prostate Cancer Diagnostics and Therapy Product
Table 114. Sanofi-Aventis Revenue in Prostate Cancer Diagnostics and Therapy Business (2019-2024) & (US$ Million)
Table 115. Sanofi-Aventis Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prostate Cancer Diagnostics and Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Prostate Cancer Diagnostics and Therapy Market Share by Type: 2023 VS 2030
Figure 3. Androgen Receptor-Directed Therapy Features
Figure 4. Taxane-Based Chemotherapy Features
Figure 5. Global Prostate Cancer Diagnostics and Therapy Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Prostate Cancer Diagnostics and Therapy Market Share by Application: 2023 VS 2030
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Prostate Cancer Diagnostics and Therapy Report Years Considered
Figure 11. Global Prostate Cancer Diagnostics and Therapy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Prostate Cancer Diagnostics and Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Prostate Cancer Diagnostics and Therapy Market Share by Region: 2023 VS 2030
Figure 14. Global Prostate Cancer Diagnostics and Therapy Market Share by Players in 2023
Figure 15. Global Top Prostate Cancer Diagnostics and Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Diagnostics and Therapy as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Prostate Cancer Diagnostics and Therapy Revenue in 2023
Figure 17. North America Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Prostate Cancer Diagnostics and Therapy Market Share by Country (2019-2030)
Figure 19. United States Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Prostate Cancer Diagnostics and Therapy Market Share by Country (2019-2030)
Figure 23. Germany Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Prostate Cancer Diagnostics and Therapy Market Share by Region (2019-2030)
Figure 31. China Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Prostate Cancer Diagnostics and Therapy Market Share by Country (2019-2030)
Figure 39. Mexico Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Share by Country (2019-2030)
Figure 43. Turkey Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Ipsen SA Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2019-2024)
Figure 46. Pfizer Inc. Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2019-2024)
Figure 47. Johnson & Johnson Services Inc. Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2019-2024)
Figure 48. Bayer AG Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2019-2024)
Figure 49. Abbvie Inc. Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2019-2024)
Figure 50. Merck & Co. Inc. Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2019-2024)
Figure 51. AstraZeneca PLC Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2019-2024)
Figure 52. Thermo Fisher Scientific Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2019-2024)
Figure 53. Dendreon Pharmaceuticals LLC Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2019-2024)
Figure 54. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2019-2024)
Figure 55. Hologic Inc. Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2019-2024)
Figure 56. Astellas Pharma Inc. Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2019-2024)
Figure 57. Koninklijke Philips NV Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2019-2024)
Figure 58. Sanofi-Aventis Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
